Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia

NCT01543477 · clinicaltrials.gov ↗

COMPLETED

Status

4501

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia
Pregnancy
Lactation

Sponsor

Pfizer

Collaborators

[object Object]